Insulin is supplied in three forms of container: Vials. Usually containing 10 ml each. Pen cartridges. Usually containing 3 ml each. Novo calls these “PenFill”: that is trademarked and not appropriate for other makes. Pre-filled disposable pens. Again usually containing 3 ml each. Note that the currently-accepted spelling is “vial”. “Phial” is a very archaic …
Most people interested in insulin pumps will by now be aware of the Medtronic 670G pump (sometimes mistakenly labelled as an “artificial pancreas”). This pump is the first commercial pump with basic hybrid closed-loop functionality, and was released in the US in 2017. There has been much discussion of when the 670G will be coming …
As someone who lives with Type 1 Diabetes, I get on with regular life just with more complexity to deal with every day. But I’m not alone! To give you an overview of how widespread this condition is in Australia in 2018, I figured it was time for a recap. The numbers I’m going to show …
Yesterday Ypsomed launched the myLife Ypsopump in Australia. It was an interesting day! To get the disclosures out of the way: Ypsomed paid for my travel and accommodation expenses to attend their event in Sydney. Along with a small cadre of other diabetes advocates and bloggers from across the country, we met with Australian and Swiss …
I’ve previously mentioned the Medtrum patch pump which received TGA approval for supply in Australia in February 2018, although we don’t yet know if anyone’s going to actually bring this to market. The pump is part of the A6 TouchCare System. Medtrum have a standalone “S6” CGM, and standalone “P6” patch pump, and the A6 system …
In April there was big news as Sanofi’s long-acting Toujeo U300 insulin was added to the Pharmaceutical Benefits Scheme (PBS) and thus became accessible to many people. It had received TGA approval some time beforehand and was available under private prescription, but the cost was significant. But at the time I failed to mention another new …